Scarica l'app Stockscreener
24.09
6.05%
-1.55
Dopo l'orario di chiusura:
24.35
0.26
+1.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché PHG Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$25.64
Aprire:
$24.68
Volume 24 ore:
2.03M
Relative Volume:
2.15
Capitalizzazione di mercato:
$21.65B
Reddito:
$19.49B
Utile/perdita netta:
$-757.52M
Rapporto P/E:
-30.55
EPS:
-0.7885
Flusso di cassa netto:
-
1 W Prestazione:
-3.76%
1M Prestazione:
+9.10%
6M Prestazione:
-9.20%
1 anno Prestazione:
-7.32%
Intervallo 1D:
$24.08
$24.77
Intervallo di 1 settimana:
$24.08
$25.86
Portata 52W:
$21.48
$32.91
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Nome
Koninklijke Philips N V Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PHG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips N V Adr
|
24.09 | 21.65B | 19.49B | -757.52M | 0 | -0.7885 |
|
ABT
Abbott Laboratories
|
133.06 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.12 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
377.52 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.32 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.92 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-25 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | Aggiornamento | UBS | Neutral → Buy |
| 2024-10-29 | Aggiornamento | Jefferies | Underperform → Hold |
| 2024-05-13 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-04-30 | Aggiornamento | UBS | Sell → Neutral |
| 2024-02-07 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | Iniziato | Goldman | Buy |
| 2023-01-17 | Downgrade | UBS | Neutral → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-10-14 | Downgrade | Deutsche Bank | Hold → Sell |
| 2022-09-12 | Aggiornamento | Societe Generale | Hold → Buy |
| 2022-09-06 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-25 | Downgrade | Societe Generale | Buy → Hold |
| 2022-06-16 | Downgrade | UBS | Neutral → Sell |
| 2022-01-20 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-14 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2022-01-12 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-08 | Iniziato | Jefferies | Buy |
| 2021-07-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-06-21 | Downgrade | HSBC Securities | Buy → Hold |
| 2021-03-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-07-28 | Iniziato | Societe Generale | Buy |
| 2019-07-30 | Iniziato | Citigroup | Buy |
| 2018-02-12 | Aggiornamento | Berenberg | Hold → Buy |
| 2017-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-10-16 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | Downgrade | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | Downgrade | Societe Generale | Buy → Hold |
| 2016-12-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | Iniziato | Citigroup | Buy |
| 2016-05-11 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2016-02-16 | Downgrade | Jefferies | Hold → Underperform |
| 2015-11-27 | Iniziato | ING Group | Hold |
| 2015-09-08 | Iniziato | Credit Suisse | Outperform |
| 2015-08-27 | Aggiornamento | Nomura | Neutral → Buy |
| 2015-07-28 | Aggiornamento | Societe Generale | Hold → Buy |
| 2011-01-25 | Downgrade | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2009-10-16 | Aggiornamento | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | Downgrade | UBS | Buy → Neutral |
Mostra tutto
Koninklijke Philips N V Adr Borsa (PHG) Ultime notizie
Lower Demand In China Disrupts Philips Q1 Sales, Cuts 2025 Profitability Target On Potential Tariff Impact - Benzinga
CBRE Group Inc (CBRE) Stock: A Closer Look at the Market Potential - News Heater
Taiwan Air Treatment Systems Industry Report: From AIoT to Wearables - GlobeNewswire Inc.
Selling Your Koninklijke Philips N.V. ADR (PHG) Stock? Here’s What You Need To Know - Stocks Register
Data-Based Insights About Koninklijke Philips N.V. ADR (PHG) - Stocks Register
Koninklijke Philips N.V. ADR (PHG) Shares Up Despite Recent Market Volatility - The News Heater
P3 Health Partners Inc (PIII) Stock: Evaluating the Annual Growth - The News Heater
Nabors Industries Ltd (NBR) Stock: A SWOT Analysis - The News Heater
Sun Country Airlines Holdings Inc (SNCY) Stock: A Value Analysis - The News Heater
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
Weekly Upgrades and Downgrades - InvestorPlace
Europe Cancer Diagnostics Market Size & Outlook, 2024-2030 - Grand View Research
Picture Archiving and Communication System Patent Landscape Report, 2024-2032 - GlobeNewswire Inc.
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Validea Kenneth Fisher Strategy Daily Upgrade Report10/29/2024 - Nasdaq
Philips has another Class I level ventilator recall - Mass Device
PHG vs. ESLOY: Which Stock Is the Better Value Option? - Yahoo Finance
China Operating Room Equipment Market Size & Outlook, 2030 - Grand View Research
New 4-Star Stocks - Morningstar
Philips to repurchase shares for up to $137.4M - Mass Device
Philips stock rises on Street-beating Q2 - Mass Device
Philips inks new multi-year patient monitoring collab - Mass Device
Philips wins FDA clearance for next-gen digital pathology system - Mass Device
GE HealthCare: Initiating Coverage With Wide Moat, Shares Look Attractive - Morningstar
Philips unveils new AI-powered cardiovascular ultrasound - Mass Device
Philips prices $758.6M offering, expands access to intracardiac echocardiography - Mass Device
Philips has positive AI-powered cardiac monitoring data - Mass Device
Philips announces exchange ratio for 2023 dividend - Philips
Philips Stock Books Record Gain After U.S. Ventilator Settlement - WSJ
Philips creates 'clear path forward' with FDA over Respironics probe - Sharecast.com
With 48% ownership in Koninklijke Philips N.V. (AMS:PHIA), institutional investors have a lot riding on the business - Yahoo Finance
Philips taps Stryker controller as next CFO - Mass Device
Philips unveils radiation-free imaging tech that uses light instead of X-ray - Mass Device
Philips unveils next-gen ultrasound systems - Mass Device
PHG Stock Quote Price and Forecast - CNN
Philips launches Visual Patient Avatar monitoring solution - Mass Device
Philips launches utrasound tech to boost cancer diagnostics - Mass Device
Philips says extended ECG Holter monitoring can improve diagnostic results - Mass Device
Markets Brief: Is the Bond Market’s Recession Indicator Broken? - Morningstar
Agnellis’ Exor Buys 15% Stake in Philips for Around $2.8 Billion - Bloomberg
Koninklijke Philips N V Adr Azioni (PHG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.82%
1.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):